Lead sponsor
University of California, Los Angeles
3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
3
Trials led
1
Active
54
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 4
1
Not applicable
1
Trials by status
Recruiting
1
Completed
1
Withdrawn
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.—not applicableRecruiting20